NEO Rehab for Infants at Risk of Cerebral Palsy

Sponsor
University of Virginia (Other)
Overall Status
Completed
CT.gov ID
NCT03372590
Collaborator
(none)
14
1
2
9.9
1.4

Study Details

Study Description

Brief Summary

Premature infants are at increased risk of developing cerebral palsy (CP). Early interventions for at risk infants have the potential to decrease disease severity and improve quality of life. All infants demonstrate general movements (GMs), which are reliable indicators of brain function and can be reproducibly evaluated using the General Movement Assessment (GMA) tool.

Prior studies have demonstrated the impact of early maternal-driven intervention strategies on neurodevelopmental outcomes in preterm infants. Investigators have shown that interventions promoting the establishment of emotional connection between the infant and his or her mother, including mother/infant calming sessions with scent cloth exchange, vocal soothing, eye contact, and kangaroo care, can impact neurodevelopmental outcomes at 18 months. Investigators have also shown that 60 minutes of kangaroo care leads to decreasing levels of the stress hormone cortisol in both mothers and infants.

This pilot study aims to determine the feasibility of a maternal-driven early intervention bundle in preterm infants with abnormal GMA.

Condition or Disease Intervention/Treatment Phase
  • Other: NICU-based rehabilitation bundle
  • Other: Standard of care
N/A

Detailed Description

The study objective are 3-fold:
  1. To determine the proportion of infants (<32 weeks gestation and/or <1500g) who have abnormal GMs findings using the GMA tool.

  2. To determine the feasibility of NICU based rehabilitation program in 20 infants determined to be at high risk for CP using the GMA tool. The intervention bundle will consist of a maternal-driven gestational age (GA)-appropriate intervention bundle that will include evidence-based interventions including vocal soothing, comforting touch, scent exchange, kangaroo care, and infant massage. Patients will be compared to contemporary and GA-matched controls receiving standard of care with a 1:2 assignment.

  3. To evaluate the short-term impact of a maternal-driven intervention bundle on the mother-infant dyad. Maternal stress will be measured using the Parental Stress Scale for NICU patients (PSS: NICU) prior to the intervention and prior to the infant's NICU discharge. Further, stress will be assessed by measuring maternal and infant salivary cortisol pre-and post-kangaroo care on 3 separate occasions (post enrollment in the study, mid-hospital stay, and prior to discharge). Measures of maternal anxiety and depression will be evaluated prior to the intervention and prior to NICU discharge using the Patient Reported Outcomes Measurement Information System (PROMIS) instrument.

The investigators hypothesize that the intervention will lead to positive and measurable outcomes for the mother-infant dyad.

Study Design

Study Type:
Interventional
Actual Enrollment :
14 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
NEO Rehabilitation Program for Premature Infants at Risk for Cerebral Palsy
Actual Study Start Date :
Sep 2, 2018
Actual Primary Completion Date :
Apr 24, 2019
Actual Study Completion Date :
Jun 30, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: NICU-based rehabilitation bundle

Patients identified to be at high risk for cerebral palsy will be enrolled after parental consent is obtained to the NICU rehabilitation program. This program consists of maternal-driven evidence based intervention that include: vocal soothing, scent exchange, comforting touch, kangaroo care, and infant massage. These intervention will be provided at GA-appropriate intervals.

Other: NICU-based rehabilitation bundle
Maternal-driven gestational age-appropriate intervention/activity bundle, including the evidence-based elements of vocal soothing, comforting touch, scent exchange, kangaroo care, and infant massage
Other Names:
  • scent exchange
  • kangaroo care
  • massage
  • vocal soothing
  • comforting touch
  • Other: Standard of care

    Infants not participating in the intervention study will be provided with standard or care. Interventions include kangaroo care, physical therapy and infant massage provided by NICU staff.

    Other: Standard of care
    Standard NICU care

    Outcome Measures

    Primary Outcome Measures

    1. NICU-based rehabilitation program feasibility [2 years]

      The feasibility of a maternal driven intervention bundle will be assessed using a maternal diary and unannounced observations. The ability to perform the required intervention greater than 75% of the time will be considered successful

    Secondary Outcome Measures

    1. Evolution of GMA patterns in high risk infants [2 years]

      GME will be scored on enrollment and at NICU discharge

    2. Impact on maternal stress and depression [2 years]

      Assessed on enrollment and NICU discharge using the PSS-NICU and PROMIS instrument

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A to 33 Weeks
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Infant Gestational age <32 weeks AND/OR birth weight <1500g
    Exclusion Criteria:
    • Any clinical condition / diagnosis that would restrict the ability of the mother to do Kangaroo Care per the current UVA Kangaroo Care guideline

    • Non-English-speaking mother

    • Mother is a prisoner

    • Confirmed inability to return for follow-up appointment

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Virginia Charlottesville Virginia United States 22908

    Sponsors and Collaborators

    • University of Virginia

    Investigators

    • Principal Investigator: Santina A Zanelli, MD, University of Virginia

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Santina Zanelli, Associate Professor of Pediatrics, University of Virginia
    ClinicalTrials.gov Identifier:
    NCT03372590
    Other Study ID Numbers:
    • 20318
    First Posted:
    Dec 13, 2017
    Last Update Posted:
    Apr 3, 2020
    Last Verified:
    Apr 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Santina Zanelli, Associate Professor of Pediatrics, University of Virginia
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 3, 2020